With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.21169-71-1,Isoxazole-5-carboxylic acid,as a common compound, the synthetic route is as follows.
Example 3 (Compound 3) N-[2-[ l-[4-chloro-3-(trifluoromethyl)phenyl]pyrazole-4-carbonyl]-4-(l- piperidyl) phenyl] isoxazole-5-carboxamide A solution of (2-amino-5-(l-pipendyl)phenyl)(l-(4-chloro-3-(tnfluoromethyl)-phenyl)- lH-pyrazol-4-yl)methanone (Intermediate 1.5) (50 umol), l,2-oxazole-5-carboxylic acid (60 umol), DIEA (150 umol) and HATU (60 umol) in DMSO (300 uL) was stirred at room temperature overnight. The residue was purified by preparative HPLC/MS_method A2 to afford the title compound. 1H NMR (DMSO-d6, 600 MHz) delta = 10.88 (s, 1H), 9.25 (s, 1H), 8.75 (d, 1H), 8.37 (d, 1H), 8.28 (dd, 1H), 8.19 (s, 1H), 7.92 (d, 1H), 7.66 (d, 1H), 7.24 (dd, 1H), 7.18 (d, 1H), 7.09 (d, 1H), 3.21 (t, 4H), 2.54 (s, OH), 1.66 – 1.59 (m, 4H), 1.58 – 1.51 (m, 2H).
21169-71-1, The synthetic route of 21169-71-1 has been constantly updated, and we look forward to future research findings.
Reference£º
Patent; LEO PHARMA A/S; SOERENSEN, Morten Dahl; LARSEN, Jens Christian Hoejland; NOERREMARK, Bjarne; LIANG, Xifu; HUANG, Guoxiang; CHEN, Jinzhong; WO2013/82756; (2013); A1;,
Isoxazole – Wikipedia
Isoxazole | C3H3NO – PubChem